COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country
(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on August 18, 2021)
Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.
Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.
For specific updates concerning China and related business advisory, please click here.
Please refresh the page to get the latest updates.
ASEAN coronavirus updates (Live updates by country)
Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.
- Brunei recorded 94 new cases on August 18, bringing the total to 946 cases amid three deaths.
- Brunei saw 65 new cases on August 17, taking the total to 852 cases amid three deaths.
- Brunei reported 64 new cases on August 16, taking the total to 787 cases amid three deaths.
Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.
- Cambodia reported 593 new cases and 12 deaths on August 18, taking the totals to 87,190 cases and 1,730 deaths.
- Cambodia saw 556 new cases and 14 deaths on August 17, bringing the tallies to 86,597 cases and 1,718 deaths.
- Cambodia recorded 593 new cases and 21 deaths on August 16, taking the totals to 86,041 cases and 1,704 deaths.
Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.
- Indonesia reported 15,768 new cases and 1,128 deaths on August 18, bringing the totals to 3,908,247 cases and 121,141 deaths.
- Indonesia saw 20,741 new cases and 1,180 deaths on August 17, taking the tallies to 3,892,479 cases and 120,013 deaths.
- Indonesia recorded 17,384 new cases and 1,245 deaths on August 16, taking the totals to 3,871,738 cases and 118,833 deaths.
Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.
- Laos reported 381 new cases on August 18, bringing the total to 11,029 cases amid nine deaths.
- Laos saw 207 new cases on August 17, taking the total to 10,648 cases amid nine deaths.
- Laos recorded 349 new cases on August 16, bringing the total to 10,441 cases amid nine deaths.
Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens.
- Malaysia reported 22,242 new cases and 225 deaths on August 18, bringing the tallies to 1,466,512 cases and 13,302 deaths.
- Malaysia saw 19,631 new cases and 293 deaths on August 17, taking the totals to 1,444,270 cases and 13,077 deaths.
- Malaysia recorded 19,740 new cases and 274 deaths on August 16, bringing the totals to 1,424,639 cases and 12,784 deaths.
Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.
- Myanmar reported 3,306 new cases and 178 deaths on August 17, bringing the tallies to 360,291 cases and 13,623 deaths.
- Myanmar saw 2,706 new cases and 182 deaths on August 16, taking the totals to 356,985 cases and 13,445 deaths.
- Myanmar recorded 2,674 new cases and 185 deaths on August 15, taking the tallies to 354,279 cases and 13,263 deaths.
The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees.
- The Philippines reported 11,085 new cases and 161 deaths on August 18, bringing the tallies to 1,776,495 cases and 30,623 deaths.
- The Philippines saw 10,035 new cases and 96 deaths on August 17, taking the totals to 1,765,675 cases and 30,462 deaths.
- The Philippines recorded 14,610 new cases and 27 deaths on August 16, taking the tallies to 1,755,846 cases and 30,366 deaths.
Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.
- Singapore reported 53 new cases on August 18, bringing the total to 66,334 cases and 45 deaths.
- Singapore saw 56 new cases and one death on August 17, taking the total to 66,281 cases and 45 deaths.
- Singapore recorded 53 new cases on August 16, taking the total to 66,225 cases amid 44 deaths.
Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.
- Thailand saw 20,515 new cases and 312 deaths on August 18, bringing the tallies to 968,957 cases and 8,285 deaths.
- Thailand reported 20,128 new cases and 239 deaths on August 17, taking the totals to 948,442 cases and 7,973 deaths.
- Thailand recorded 21,157 new cases and 182 deaths on August 16, bringing the tallies to 928,314 cases and 7,734 deaths.
Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.
Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.
As of August 18, 2021, Vietnam’s Ministry of Health confirmed a total of 302,101 cases of COVID-19. However, 111,308 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 6,770 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Long An, Tien Giang, and Dong Nai among others.
- Vietnam saw 9,605 new cases and 331 deaths on August 17, taking the tallies to 293,301 cases and 6,472 deaths.
As of August 16, 2021, Vietnam’s Ministry of Health confirmed a total of 275,044 cases of COVID-19. However, 102,504 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 6,141 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, Long An, and Dong Thap among others.
Other Asian countries and Regions
Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either.
- Afghanistan has 152,411 cases and 7,047 deaths as of August 18.
- As of August 17, Afghanistan has 152,363 cases and 7,043 deaths.
- Afghanistan has 152,243 cases and 7,031 deaths as of August 16.
Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.
- Bangladesh has 1,440,644 cases and 24,719 deaths as of August 18.
- Bangladesh has 1,433,396 cases and 24,547 deaths as of August 17.
- As of August 16, Bangladesh has 1,425,861 cases and 24,349 deaths.
Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.
- Bahrain has 271,130 cases and 1,384 deaths as of August 17.
- Bahrain has 271,025 cases and 1,384 deaths as of August 16.
- Bahrain has 270,919 cases and 1,384 deaths as of August 15.
For specific updates concerning China, please click here.
For a complete overview of China’s vaccine availability please go here.
- China reported 28 new cases on August 18, taking the total to 94,500.
- China reported 42 new cases on August 17, bringing the total to 94,472.
- China saw 51 new cases on August 16, taking the total to 94,430.
East Timor is receiving assistance from the Gavi Institute.
- As of August 18, East Timor has 13,155 cases and 40 deaths.
- East Timor has 12,929 cases and 38 deaths as of August 17.
- East Timor has 12,682 cases and 33 deaths as of August 16.
Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.
- As of August 18, Hong Kong has 12,043 cases and 212 deaths.
- Hong Kong has 12,040 cases and 212 deaths as of August 17.
- Hong Kong has 12,037 cases and 212 deaths as of August 16.
For a complete overview of India’s vaccine availability please go here.
- India has 32,285,101 cases and 432,552 deaths as of August 17.
- As of August 16, India has 32,249,900 cases and 432,112 deaths.
- Our new India-specific updates can be found here.
Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.
- As of August 18, Iran has 4,556,417 cases and 99,691 deaths.
- Iran has 4,517,243 cases and 99,108 deaths as of August 17.
- Iran has 4,467,015 cases and 98,483 deaths as of August 16.
Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021.
- As of August 17, Iraq has 1,793,372 cases and 19,815 deaths.
- Iraq has 1,784,594 cases and 19,740 deaths as of August 16.
- Iraq has 1,775,764 cases and 19,672 deaths as of August 15.
Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021.
- As of August 18, Japan has 1,179,176 cases and 15,467 deaths.
- Japan has 1,159,945 cases and 15,431 deaths as of August 17.
- Japan has 1,144,546 cases and 15,408 deaths as of August 16.
Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021.
- Jordan has 785,697 cases and 10,239 deaths as of August 17.
- As of August 16, Jordan has 784,631 cases and 10,222 deaths.
- Jordan has 783,448 cases and 10,213 deaths as of August 15.
Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.
- As of August 18, Kazakhstan has 708,379 cases and 7,867 deaths.
- Kazakhstan has 701,345 cases and 7,751 deaths as of August 17.
- Kazakhstan has 694,476 cases and 7,652 deaths as of August 16.
All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.
- Kuwait has 407,139 cases and 2,395 deaths as of August 17.
- As of August 16, Kuwait has 406,883 cases and 2,393 deaths.
- Kuwait has 406,540 cases and 2,389 deaths as of August 15.
Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021.
- Kyrgyzstan has 172,937 cases and 2,462 deaths as of August 18.
- As of August 17, Kyrgyzstan has 172,668 cases and 2,457 deaths.
- Kyrgyzstan has 172,327 cases and 2,451 deaths as of August 16.
Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.
- Lebanon has 584,896 cases and 7,988 deaths as of August 17.
- As of August 16, Lebanon has 583,718 cases and 7,982 deaths.
- Lebanon has 583,012 cases and 7,976 deaths as of August 15.
Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.
- As of August 4, Macau has 63 cases.
- Macau has 59 cases as of July 25.
- As of July 24, Macau has 58 cases.
The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.
- The Maldives has 79,419 cases and 222 deaths as of August 17.
- As of August 16, the Maldives has 79,289 cases and 222 deaths.
- The Maldives has 79,137 cases and 222 deaths as of August 15.
Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021.
- Mongolia has 186,537 cases and 889 deaths as of August 18.
- As of August 17, Mongolia has 184,950 cases and 884 deaths.
- Mongolia has 183,652 cases and 880 deaths as of August 16.
Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.
- Nepal has 739,907 cases and 10,396 deaths as of August 18.
- As of August 17, Nepal has 737,294 cases and 10,354 deaths.
- Nepal has 734,838 cases and 10,327 deaths as of August 16.
North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.
- North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.
Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).
- Oman has 300,728 cases and 4,013 deaths as of August 18.
- Oman has 300,581 cases and 4,007 deaths as of August 17.
- As of August 16, Oman has 300,408 cases and 3,999 deaths.
Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021.
- As of August 18, Pakistan has 1,109,274 cases and 24,639 deaths.
- Pakistan has 1,105,300 cases and 24,573 deaths as of August 17.
- Pakistan has 1,102,079 cases and 24,478 deaths as of August 16.
Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.
- Palestine has 321,031 cases and 3,625 deaths as of August 16.
- As of August 14, Palestine has 320,034 cases and 3,623 deaths.
- Palestine has 319,646 cases and 3,622 deaths as of August 13.
Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021.
- Qatar has 229,915 cases and 601 deaths as of August 18.
- Qatar has 229,697 cases and 601 deaths as of August 17.
- As of August 16, Qatar has 229,428 cases and 601 deaths.
A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.
- Russia has 6,663,473 cases and 172,909 deaths as of August 18.
- Russia has 6,642,559 cases and 172,110 deaths as of August 17.
- Our new Russia-specific updates here.
Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021.
- As of August 18, Saudi Arabia has 540,244 cases and 8,439 deaths.
- Saudi Arabia has 539,698 cases and 8,431 deaths as of August 17.
- Saudi Arabia has 539,129 cases and 8,419 deaths as of August 16.
South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021.
- As of August 18, South Korea has 228,657 cases and 2,178 deaths.
- South Korea has 226,854 cases and 2,173 deaths as of August 17.
- South Korea has 225,481 cases and 2,167 deaths as of August 16.
Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.
- As of August 17, Sri Lanka has 365,683 cases and 6,434 deaths.
- Sri Lanka has 362,074 cases and 6,263 deaths as of August 16.
- Sri Lanka has 354,968 cases and 6,096 deaths as of August 15.
Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.
- Taiwan has 15,891 cases and 821 deaths as of August 18.
- Taiwan has 15,880 cases and 821 deaths as of August 17.
- As of August 16, Taiwan has 15,862 cases and 821 deaths.
Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.
- As of August 17, Turkey has 6,118,508 cases and 53,507 deaths.
- Turkey has 6,096,816 cases and 53,324 deaths as of August 16.
- Turkey has 6,078,653 cases and 53,159 deaths as of August 15.
United Arab Emirates
The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates. The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.
- As of August 17, the UAE has 704,000 cases and 2,006 deaths.
- The UAE has 702,885 cases and 2,003 deaths as of August 16.
- The UAE has 701,776 cases and 2,001 deaths as of August 15.
Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021.
- As of August 17, Uzbekistan has 144,764 cases and 987 deaths.
- Uzbekistan has 143,918 cases and 981 deaths as of August 16.
- Uzbekistan has 143,041 cases and 976 deaths as of August 15.
Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.
- Yemen has 7,347 cases and 1,407 deaths as of August 17.
- Yemen has 7,308 cases and 1,405 deaths as of August 16.
- Yemen has 7,293 cases and 1,403 deaths as of August 15.
ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in Singapore, Hanoi, Ho Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at email@example.com or visit our website at www.dezshira.com.